Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2023 2
2024 15
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
PSMA PET/CT in biochemical recurrence of prostate cancer with PSA levels ≤ 0.2 ng/mL: a German multicenter analysis of conventional PSMA tracers, including [68Ga]Ga-PSMA-11, [68Ga]Ga-PSMA I&T, and [18F]PSMA-1007.
Burgard C, Frei M, Blickle A, Hartrampf PE, Hoffmann MA, Schreckenberger M, Schmid HP, Unterrainer L, Rogasch J, Galler M, Ezziddin S, Rosar F. Burgard C, et al. Among authors: blickle a. Eur J Nucl Med Mol Imaging. 2025 Apr 30. doi: 10.1007/s00259-025-07292-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 40304782
225 Ac-PSMA-617 Augmentation After Insufficient Response Under 177 Lu-PSMA-617 Radioligand Therapy in mCRPC: Evaluation of Outcome and Safety From a Prospective Registry (REALITY Study).
Rosar F, Khreish F, Nagel LS, Blickle A, Burgard C, Petto S, Bastian MB, Speicher T, Bartholomä M, Maus S, Schaefer-Schuler A, Ezziddin S. Rosar F, et al. Among authors: blickle a. Clin Nucl Med. 2025 Apr 1;50(4):e202-e206. doi: 10.1097/RLU.0000000000005640. Epub 2024 Dec 31. Clin Nucl Med. 2025. PMID: 39787407
Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing [225Ac]Ac-PSMA-617-Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy.
Burgard C, Khreish F, Dahlmanns L, Blickle A, Bastian MB, Speicher T, Maus S, Schaefer-Schuler A, Bartholomä M, Petto S, Ezziddin S, Rosar F. Burgard C, et al. Among authors: blickle a. Cancers (Basel). 2024 Oct 19;16(20):3532. doi: 10.3390/cancers16203532. Cancers (Basel). 2024. PMID: 39456626 Free PMC article.
20 results